Duska LR

No ORCID on file · 4 papers in corpus
other 2025
Trends in Volume of Benign Hysterectomies Performed by Gynecologic Oncologists, 2015-2021: A National Surgical Quality Improvement Project Analysis
Journal of Minimally Invasive Gynecology ·doi:10.1016/j.jmig.2025.04.012

STUDY OBJECTIVE: To evaluate national trends in the surgical volume of benign hysterectomies and trends in the percentage of benign hysterectomies performed by gynecologic oncologists (GOs) in the United States through analysis of the Natio…

case-report 2024
Large bowel recurrence of endometrial adenocarcinoma years after treatment: A single-institution case series and review of the literature
Gynecologic oncology reports ·doi:10.1016/j.gore.2024.101336

Endometrial cancer (EC) is the most common gynecologic cancer in the United States. A majority of new cases are diagnosed as low-grade International Federation of Gynecology and Obstetrics (FIGO) Stage I, with a recurrence risk cited as les…

2017
The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications.
Annals of oncology : official journal of the European Society for Medical Oncology ·doi:10.1093/annonc/mdx445

The roles of histologic characterization and staging are to provide reproducible metrics for cancer classification with which to direct the most appropriate clinical care and to yield the most stable reliable system to allow both prospectiv…

other 2010
When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes
Gynecologic Oncology ·doi:10.1016/j.ygyno.2009.10.069

OBJECTIVE: To determine the incidence of clinically significant venous thromboembolism (VTE) in women diagnosed with clear cell carcinoma of the ovary (CCC-O) interpreted in the context of Centers for Medicare and Medicaid Services (CMS) 'n…